Related Experiment Videos
Hepatocyte growth factor and cardiovascular thrombosis in patients admitted to the intensive care unit
Noritake Hata1, Akira Matsumori, Shinya Yokoyama
1Department of Intensive Care Unit, Chiba Hokusoh Hospital, Nippon Medical School, Chiba, Japan. hata-n@nms.ac.jp
Insights
Hepatocyte growth factor (HGF) levels are higher in patients with acute coronary syndrome and other thrombotic conditions. This study found increased serum HGF correlates with the presence of thrombi in these patients.
Area of Science:
- Cardiology
- Biochemistry
Background:
- Hepatocyte growth factor (HGF) is a known marker for atherosclerosis and thrombi synthesis.
- The direct relationship between HGF and confirmed coronary thrombi has not been previously established.
Purpose of the Study:
- To investigate the association between serum HGF concentrations and the presence of coronary thrombi in patients presenting with chest pain.
Main Methods:
- Serum HGF levels were measured using enzyme-linked immunosorbent assay (ELISA) in 107 patients with chest pain.
- Thrombi presence was assessed via angiography, intravascular ultrasonography, angioscopy, and computed tomography.
Main Results:
- Serum HGF was significantly elevated in patients with acute myocardial infarction (AMI), unstable angina, acute aortic dissection, and pulmonary thromboembolism compared to stable angina.
- Patients with confirmed thrombi exhibited higher serum HGF concentrations than those without (326.7 pg/ml vs 226.9 pg/ml).
Conclusions:
- Elevated serum HGF concentrations are correlated with the presence of thrombi.
- This finding applies to patients diagnosed with acute coronary syndrome, acute aortic dissection, and pulmonary thromboembolism.
Background:
Hepatocyte growth factor (HGF) has been reported as a marker of atherosclerosis and of thrombi synthesis, but the relationship between HGF and proven coronary thrombi has not been described. The aim of this study was to investigate this relationship in patients with chest pain.
Methods And Results:
The study group comprised 107 patients with chest pain (61 acute myocardial infarction (AMI), 18 unstable angina, 15 stable angina, and 13 others; 65 males, 42 females; 66+/-11 years old). The presence of thrombi was evaluated by angiography, intravascular ultrasonography, angioscopy, and computed tomography. Serum HGF concentrations were measured using a new enzyme-linked immunosorbent assay. Serum HGF was significantly higher in the patients with AMI (335.0 +/-197.5 pg/ml), unstable angina (269.1+/-152.7 pg/ml), acute aortic dissection (320.3+/-116.5 pg/ml), and pulmonary thromboembolism (292.5+/-101.9 pg/ml), than in those with stable angina (171.2+/-56.1 pg/ml). Serum HGF concentration was also higher in those patients with proven thrombi than in those patients without (326.7+/-189.7 pg/ml vs 226.9+/-110.8 pg/ml).
Conclusion:
Increased serum HGF concentrations correlate with the presence of thrombi in patients with acute coronary syndrome, acute aortic dissection, and pulmonary thromboembolism.
Related Concept Videos
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Cirrhosis II: Pathophysiology
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Venous Thrombosis III: Interprofessional Care
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...